Search
Close this search box.
Subscriber Log In
Search

THOUGHT LEADERSHIP

Catch up with our insights on the big issues in pharma.

Our thought leadership library brings you our latest data-driven reports, infographics and articles that tackle the big issues, interesting niches and everything in between.

Latest Content

EVALUATING: Neurology
Neurology is experiencing a resurgence, highlighted by increased deal activity, clinical advancements and a notable IPO. This revival, though less conspicuous than obesity’s, emerges from years of underinvestment, resulting in a landscape filled...
Read More
Biopharma-2022-Whats-Next-featured-image
Antibody Drug Conjugates Report
Antibody-drug conjugates (ADCs) are the hottest real estate in oncology, attracting billions from big pharma: Pfizer acquired Seagen for $43 billion AbbVie invested over $10 billion in ImmunoGen Merck committed $4 billion upfront, with a potential total...
Read More
Antibody-Drug-Conjugates-Report-featured-image
Galen Growth: Digital Health 2023 Year End Report
In 2023, the digital health ecosystem witnessed notable consolidation, increased investor scrutiny and a decline in investor support. Health systems prioritised operational efficiency and big tech made strategic investments in emerging AI capabilities. This...
Read More
Galen-Growth-Digital-Health-2023-Year-End-Report-featured-image
More content

Featured Contributors